Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD

Lee, James; Grizenko, Natalie; Bhat, Venkataramana; Sengupta, Sarojini; Polotskaia, Anna; Ridha Joober
January 2011
BMC Psychiatry;2011, Vol. 11 Issue 1, p70
Academic Journal
Background: The desired (therapeutic) and undesired (side) effects of methylphenidate might have underlying correlations. The aim of this study was to explore the strength and the possible sources of these correlations. Methods: One hundred and fifty-seven children with ADHD (6-12 years) were administered placebo and methylphenidate (0.5 mg/kg in a divided b.i.d. dose), each for a one-week period, in a double-blind, crossover trial. Therapeutic response was assessed using the Conners' Global Index for parents (CGI-Parents) and teachers (CGITeachers), while side effects were assessed using the Barkley Side Effects Rating Scale (SERS). Results: The side effect profile as assessed by the SERS was similar to that of previous studies with insomnia, decreased appetite, and headaches showing significant treatment effects (p < 0.005). These "somatic/physical" side effects did not correlate with CGI-Parents or CGI-Teachers. However, the side effects of "irritability", "proneness to crying", and "anxiousness" showed significant relationships with CGI-Parents. These "mood/anxiety" side effects showed no significant correlations with the CGI-Teachers. Conclusion: The greater "mood/anxiety" side effects on methylphenidate and placebo, the less the parents observe improvement of their children while treated with methylphenidate. This suggests that the correlations between "mood/anxiety" side effects and poor response to treatment may be driven by observer effects rather than biological commonalities between therapeutic and side effects of methylphenidate.


Related Articles

  • Methylphenidate.  // Reactions Weekly;1/24/2009, Issue 1236, p24 

    The article describes the case of a 9-year-old boy with attention-deficit hyperactivity disorder (ADHD) who experienced nocturnal bruxism following treatment with methylphenidate. Clinical improvement of the ADHD symptoms was noted after receiving methylphenidate. However, he developed nocturnal...

  • Methylphenidate-induced mania-like symptoms. Chakraborty, Kaustav; Grover, Sandeep // Indian Journal of Pharmacology;Feb2011, Vol. 43 Issue 1, p80 

    Therapeutic dose of methylphenidate is known to cause adverse effects (psychosis or mania), albeit in a small number of cases. Signs and symptoms of adverse effects usually disappear on stopping the medicine. Data regarding the safety of methylphenidate in comorbid attention deficit...

  • Methylphenidate interaction.  // Reactions Weekly;5/19/2007, Issue 1152, p17 

    The article describes three cases involving two girls and a boy aged 5-15 years, who had attention-deficit hyperactivity disorder (ADHD), who developed agitation and irritability after treatment with risperidone was switched to methylphenidate. The symptoms of the boy were well controlled with...

  • The Homeopathic Treatment of Attention Deficit Disorders. Ullman, Dana // Latitudes;2002, Vol. 5 Issue 4, p20 

    Discusses the effectiveness of homeopathic treatment for children with Attention Deficit Disorders (ADD). Short-term side effects associated with drug ritalin used for treating children with ADD; Prescription of homeopathic medicine on individual basis; Comparison of homeopathic treatment with...

  • ATTENTION DEFICIT DISORDER. Leo, Jonathan // Skeptic;2000, Vol. 8 Issue 1, p63 

    Focuses on the use of Ritalin as a drug treatment for children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) in the United States. Percentage of Ritalin consumed by American children; Role of marketing in the acceptance of treating children with mind altering drugs; Absence of...

  • Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder: An Update. Awudu, Gariba; Besag, Frank // Drug Safety;Sep2014, Vol. 37 Issue 9, p661 

    Several million children and a growing number of adults are currently being treated for attention-deficit hyperactivity disorder (ADHD) worldwide. Concerns have been expressed about possible cardiac effects of the common treatments, namely methylphenidate, amphetamines and atomoxetine. Small...

  • Ritalin and cancer.  // Second Opinion;Jul96, Vol. 6 Issue 7, p2 

    Discusses the lack of scientific evidence showing that the drug Ritalin or methylphenidate causes cancer in children. Use of the drug to treat children with attention-deficit disorder (ADD); Probability that ADD is a wrongly labeled disease; Action to take in using proper lighting to help ADD...

  • COULD A SCHOOL FORCE YOUR CHILD TO TAKE RITALIN? Engeler, Amy // Redbook;Oct2001, Vol. 197 Issue 4, p101 

    Relates the experience of Jill and Michael Carroll who fought to take their attention-deficit-disordered child off the drug Ritalin.

  • Dexmethylphenidate - Novartis/Celgene: Focalinâ„¢, D-MPH, D-Methylphenidate Hydrochloride, D-Methylphenidate, Dexmethylphenidate, Dexmethylphenidate Hydrochloride.  // Drugs in R&D;2002, Vol. 3 Issue 4, p279 

    Celgene has developed a chirally pure form of methylphenidate (Ritalin), called dexmethylphenidate [d-methylphenidate, d-methylphenidate hydrochloride, d-MPH; Focalinâ„¢]. The drug has been launched in the USA and is undergoing registration in Canada for the treatment of children with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics